US Regulatory Roundup – September 2022: Philips Troubles, Software And User Fees

The ten most popular stories about US regulatory issues published by Medtech Insight last month were a mixed bag, with a Philips recall taking the top spot and stories about AI, user fees, and more adding to the list.

Medtech Insight readers remained tuned into the ongoing saga of Royal Philips’ recalls in September, while stories about user fees, software and artificial intelligence also commanded attention.

The most-read US regulatory story for September was Another Headache For Philips As Company Recalls Millions Of Sleeping Masks,...